G. H. Rabbani

Publication List Details

Period

1979 - 2007

Number

74

Co-Authors

Intestinal transport of different electrolyte solutions across small intestine of rabbit in vivo (2007)

Islam, S., Rahman, A ., Fuchs, G.J., Chowdhury, A.K., Wahed, M.A., Rabbani, G.H.

Objective: Determine the relative effects of different electrolyte solutions in optimizing intestinal absorption of water and electrolytes. Methodology: The rice electrolyte solutions, called...

Evaluation of the plant extract (Hirtacin) in a rabbit model of shigellosis (2007)

Rahman, Qazi Khaleda, Ahsan, Chowdhury Rafiqul, Ahmed, Kamaluddin, Rabbani, G.H.

Objective: Evaluate the efficacy of the plant extract hirtacin in a rabbit model of shigellosis. Methodology: Cecal-ligated rabbits were inoculated with Shigellaflexneri 2a, and after 24 hours, three...

Role of nitric oxide in the pathogenesis of shigellosis and cholera in children (2007)

Islam, Sufia, Fuchs, G.J., Chowdhury, A.K., Rahman, A., Miller, M., Rabbani, G.H.

Objective: Evaluate the role of nitric oxide in the pathogenesis of shigeltosis and cholera in children. Methodology: Concentrations of nitrite, a stable metabolite of nitric oxide (by Griess...

Potential invasive properties of vibrio cholerae O139 bengal in a rabbit model: a preliminary study (2007)

Khan, A.M., Bhattacharya, M.K., Rabbani, G.H., Fuchs, G.J.

Objective: Study the invasive properties of Vibrio cholerae 0139 Bengal. Methodology: Adult New Zealand white rabbits were used. Closed intestinal loops of 10-cm length, following appropriate...

Oxidative stress in patients with severe cholera (2007)

Khaled, M.A., Rabbani, G.H.

Objective: Determine the adverse metabolic effects of oxidative stress in cholera. Oxidative stress is an adverse metabolic condition induced by the Reactive Oxygen Species (ROS). These ROS are...

Inhibition of cholera toxin-induced salt and water secretion by short-chain fatty acids in vivo (2007)

Rabbani, G.H., Rahman, H., Mahalanabis, Dilip

Objective: Determine the effect of SCFAs on cholera toxin-induced colonic secretion. Short-chain fatty acids (acetate, propionate, butyrate) produced by the fermentation of unabsorbed carbohydrates...

Cholera toxin stimulates absorption of d-glucose from the adult rabbit small intestine in vivo (2007)

Bhattacharya, M.K., Rabbani, G.H., Mazumder, R.N., Khan, A.M., Hossain, Motaher, Mahalanabis, Dilip

Objective: Determine the effects of purified cholera toxin (CT) on intestinal absorption of glucose. Glucose is known to stimulate intestinal sodium absorption which provides the basis for the...

Short-chain fatty acids inhibit fluid and electrolyte loss induced by cholera toxin in proximal colon of rabbit in vivo (1999)

Rabbani, G.H., Albert, M. John, Rahman, Hamidur, Chowdhury, Asis Kumar

Short-chain fatty acids (SCFA), acetate, propionate, and butyrate, are produced by bacterial fermentation in the colon and stimulate Na+ and Cl- absorption. We have studied the effects of SCFA on...

Short-chain fatty acids improve clinical, pathologic, and microbiologic features of experimental shigellosis (1999)

Rabbani, G.H., Albert, M.J., Islam, K.M. Nasirul, Alam, K.

Because of the metabolic and antibacterial actions of short-chain fatty acids (SCFA), their roles in modifying the clinicopathologic features of shigellosis were evaluated in a rabbit model of...

Standardized management reduces mortality among severely malnourished children with diarrhoea (1998)

Ahmed, T., Ali, M., Ullah, M., Choudhury, I. A., Begum, B., Haque, M.E., ...

Objective: Reduce mortality and cost of treating severely malnourished children with diarrhoea by following a standardized management protocol. Methodology: The mortality rates and the cost of...

Gastric acid secretion and enteric infection in Bangladesh (1997)

Evans, Carlton A. W., Gilman, Robert H., Rabbani, G.H., Salazar, Guillermo, Ali, Akbar

In developing countries many enteric infections are caused by acid-sensitive pathogens. Failure of the gastric acid barrier to infection has been reported in cholera but gastric acid secretion has...

Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a (1995)

Rabbani, G.H., Albert, M. John, Rahman, Hamidur, Islam, Moyenul, Mahalanabis, Dilip, Kabir, I., ...

Rabbits are not usually susceptible to intestinal Shigella infection without extensive pretreatment, including starvation and administration of antimicrobial, antimotility, and toxic agents (carbon...

Clinical trial of clonidine hydrochloride as an antisecretory agent in cholera (1989)

Rabbani, G.H., Butler, Thomas, Patte, Didier, Abud, Rodney L.

Clonidine hydrochloride (an alpha 2-adrenoceptor agonist) was tested for antisecretory effects in patients with cholera in a randomized controlled trial. Nineteen adults with diarrhea due to Vibrio...

Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae (1987)

Rabbani, G.H., Butler, Thomas, Knight, Joseph, Sanyal, S.C., Alam, Khorshed

To evaluate the antisecretory activity of berberine sulfate (BS), we studied 165 adult patients with acute diarrhea due to enterotoxigenic Escherichia coli (ETEC) and Vibrio cholerae in randomized...

Indomethacin and chloroquine fail to inhibit fluid loss in cholera (1985)

Rabbani, G.H., Butler, Thomas

A randomized, controlled trial was conducted to investigate the ability of indomethacin and chloroquine to reduce intestinal secretion in 29 adult patients with severe cholera. All patients received...

Increased jejunal prostaglandin E2 concentrations in patients with acute cholera (1985)

Speelman, P., Rabbani, G.H., Bukhave, K., Rask-Madsen, J

Supraphysiologic doses of prostaglandins (PGs) mimic the effect of cholera toxin and cAMP in the small intestine, but not all observations are explicable in terms of the theory that links PGs to...

The treatment of Fasciolopsis buski infection in children: a comparison of thiabendazole, mebendazole, levamisole, pyrantel pamoate, hexylresorcinol and tetrachloroethylene (1985)

Rabbani, G.H., Gilman, R.H., Kabir, I., Mondel, Gabriel

Four relatively new broad spectrum anthelmintics (thiabendazole, mebendazole, levamisole and pyrantel pamoate) were compared with two older anthelmintics, (tetrachloroethylene and hexylresorcinol) to...

Reduction of fluid-loss in cholera by nicotinic acid: a randomised controlled trial (1983)

Rabbani, G.H., Butler, Thomas, Bardhan, P.K ., Islam, Asma

A randomised controlled clinical trial was conducted to investigate the ability of nicotinic acid to reduce intestinal secretion in patients with severe cholera. Of the 62 adults investigated, 29...

The use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases (1982)

Islam, M.R., Sack, David A., Holmgren, Jan, Bardhan, P.K., Rabbani, G.H.

Four hundred and ten patients with severe watery diarrhea; including 316 patients with cholera, were studied in a double-blind, randomized, placebo controlled trial to determine if chlorpromazine (1...

Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously (1982)

Rabbani, G.H., Greenough III, W.B., Holmgren, J., Kirkwood, B.

A randomised controlled trial was conducted to investigate the ability of chlorpromazine to reduce intestinal secretion in cholera. Chlorpromazine had reduced loss of intestinal fluid in animals with...

Chlorpromazine reduces fluid-loss in cholera (1979)

Rabbani, G.H., Greenough, William B. III, Holmgren, J., Lönnroth, I.

Because chlorpromazine inhibited cholera-toxin-stimulated intestinal adenylate cyclase and fluid secretion in laboratory animals its ability to reduce fluid-loss in human cholera was investigated....

Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.

Rabbani, G H, Islam, M R, Butler, T, Shahrier, M, Alam, K

To evaluate single doses of 400 mg of furazolidone and 1 g of tetracycline given orally to patients with diarrhea due to Vibrio cholerae, we studied 87 adults in a randomized, double-blind,...

Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a.

Rabbani, G H, Albert, M J, Rahman, H, Islam, M, Mahalanabis, D, Kabir, I, ...

Rabbits are not usually susceptible to intestinal Shigella infection without extensive pretreatment, including starvation and administration of antimicrobial, antimotility, and toxic agents (carbon...

Efficacy of a single dose of furazolidone for treatment of cholera in children.

Rabbani, G H, Butler, T, Shahrier, M, Mazumdar, R, Islam, M R

To test the efficacy and safety of furazolidone given as a single dose for childhood cholera, a randomized double-blind placebo-controlled trial was carried out among 118 culture-positive dehydrated...

Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously.

Rabbani, G H, Greenough, W B, Holmgren, J, Kirkwood, B

A randomised controlled trial was conducted to investigate the ability of chlorpromazine to reduce intestinal secretion in cholera. Chlorpromazine had reduced loss of intestinal fluid in animals with...

Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.

Rabbani, G H, Islam, M R, Butler, T, Shahrier, M, Alam, K

To evaluate single doses of 400 mg of furazolidone and 1 g of tetracycline given orally to patients with diarrhea due to Vibrio cholerae, we studied 87 adults in a randomized, double-blind,...

Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a.

Rabbani, G H, Albert, M J, Rahman, H, Islam, M, Mahalanabis, D, Kabir, I, ...

Rabbits are not usually susceptible to intestinal Shigella infection without extensive pretreatment, including starvation and administration of antimicrobial, antimotility, and toxic agents (carbon...

Efficacy of a single dose of furazolidone for treatment of cholera in children.

Rabbani, G H, Butler, T, Shahrier, M, Mazumdar, R, Islam, M R

To test the efficacy and safety of furazolidone given as a single dose for childhood cholera, a randomized double-blind placebo-controlled trial was carried out among 118 culture-positive dehydrated...

Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously.

Rabbani, G H, Greenough, W B, Holmgren, J, Kirkwood, B

A randomised controlled trial was conducted to investigate the ability of chlorpromazine to reduce intestinal secretion in cholera. Chlorpromazine had reduced loss of intestinal fluid in animals with...

Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera.

Van Loon, F P, Rabbani, G H, Bukhave, K, Rask-Madsen, J

Human cholera is associated with an increased luminal release of prostaglandin E2 (PGE2), but whether inhibition of increased PGE2 synthesis will reduce or control intestinal secretion is uncertain....

Increased jejunal prostaglandin E2 concentrations in patients with acute cholera.

Speelman, P, Rabbani, G H, Bukhave, K, Rask-Madsen, J

Supraphysiologic doses of prostaglandins (PGs) mimic the effect of cholera toxin and cAMP in the small intestine, but not all observations are explicable in terms of the theory that links PGs to...